Coverage will likely include:
- Innovations in biophysical tools for screening fragment libraries (e.g. 19F NMR, affinity-selective mass spec)
- Covalent fragments, especially for targeted protein degradation (TPD)
- Growing fragment hits in the absence of information from x-ray crystallography
- DNA-Encoded Libraries (DEL) and other new approaches for fragment library design
- Case studies on FBDD enabling progress against difficult targets
- Fragment 'assisted' drug design: lead generation based on various hit-finding campaigns
- Fragment 'success' stories (examples of fragment-origin drug candidates or recent launches)
The deadline for priority consideration is September 15, 2023.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
We hope you can join us for the 5 concurrent day-and-a-half conferences during each half of our 19th Annual Drug Discovery Chemistry event. Registering for this conference lets you also move back and forth among parallel programs to create your own agenda.
Opportunities for Participation: